Partnership agreement signed between Salvator Mundi International Hospital and UPMC

No comments
An agreement was signed between Salvator Mundi International Hospital and UPMC (University of Pittsburgh Medical Center) to co-manage the Hospital and carry out investments and collaborations in the field of private health care that will benefit Italian and foreign patients, and with the goal to extend Rome's power of attraction to a wider area that includes Europe, the Mediterranean, and beyond.

In particular, an integrated Oncology Center will be created and linked to the UPMC Cancer Center network. In line with the professional experience of the two partners, the plan is to launch new programs and to improve the existing ones, including thoracic and abdominal minimally invasive surgical oncology, interventional radiology, and oncology interventional digestive endoscopy. The oncology clinical offer will be complemented by immuno-oncology therapies and a new oncology genomics service, indispensable to support therapeutic decisions with a personalized medicine approach. All aspects related to the prevention and early diagnosis of oncological diseases will also be developed, and a new dedicated program of Integrative Medicine in Oncology, one of the first in Europe, will be launched. The program will be managed by a team of physicians and experts, and will support patients and their families, helping them manage the symptoms of the disease and the side effects of the therapies.

The aim of the new SMIH-UPMC partnership is also to enhance and expand the offer across multiple specialties including orthopedics, ophthalmology, and plastic surgery, using new technologies and innovative approaches (such as, for example, regenerative medicine). A strong focus will also be placed on the most serious current public health issues, launching integrated and multidisciplinary programs to treat obesity and improve the management of age-related conditions.

The agreement also provides for collaborations in the field of research and development, levering on the European and international nature of the Hospital.

UPMC is present in Italy with its subsidiary UPMC Italy since 1997, with the management of IRCCS- ISMETT (Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione), UPMC San Pietro FBF Advanced Radiotherapy Center, and UPMC Institute for Health Chianciano Terme.

The clinical and research facilities of UPMC in Italy and of Salvator Mundi International Hospital will work in synergy to offer patients a wide range of care, innovative treatments, advanced protocols, and customized physical exercise and rehabilitation programs.

Bruno Gridelli, executive vice president of UPMC International, commented the new agreement: “UPMC Hillman Cancer Center is one of the largest and most advanced care and research centers in the U.S. The presence and the role of UPMC at Salvator Mundi International Hospital will allow patients coming to this excellent hospital to access the best oncology care, thanks to the joint efforts of physicians, nurses, and administrative staff in Rome and in Pittsburgh. SMIH will rapidly become on the most important private oncology centers in Rome and in Italy.”

Michele Casciani expressed great satisfaction for this collaboration, which paves the way to the development of a no longer “marginal” private health care, finally with an active role in the international – and also scientific – context. A private health care based on solid clinical safety protocols and state-of-the-art technologies and systems. Mr. Casciani underlined how UPMC is the ideal partner for this program, in consideration of its considerable experience that is not limited to technologies and “clinical excellence” but that extends towards the broadest and more complex aspects of the health industry, such as the integration of clinical facilities with the insurance companies, an area of growing interest in Italy.

No comments

Post a Comment